LONDON, Sept. 23, 2024 /PRNewswire/ — VeriPark, a Microsoft Solutions Partner in the Financial Services Industry, has been selected for the Business Applications 2024-2025 Microsoft Inner Circle and the Microsoft Financial Services Partner Advisory Council.

Participation within Inner Circle is based on sales achievements that rank VeriPark in the top echelon of Microsoft’s Business Applications global network of partners. Inner Circle members are known for performing at a high-level by delivering innovative solutions that help organizations excel.

Ozkan Erener, CEO VeriPark: “We are honored to once again be recognized by Microsoft for our commitment to driving digital transformation for our clients. Partnering closely with Microsoft allows us to harness the latest technologies to revolutionize the Financial Services Industry. This recognition highlights the success of our collaborative strategy and execution.“

VeriPark first joined Microsoft’s Inner Circle in 2011 and has since provided innovative solutions that help financial institutions achieve a competitive advantage. By leveraging Microsoft’s platform, VeriPark continues to offer unparalleled services and solutions to its clients.

“Partners achieving the Inner Circle demonstrate an exceptional impact helping customers accelerate their AI and digital transformation with Dynamics 365 and Power Platform,” said Peter Jensen, Microsoft Business Application Partner Strategy Lead. “Microsoft AI Cloud Partner Program partners who achieve the Business Application Inner Circle distinction stand out for their deep AI, Cloud and Industry knowledge.”

Additionally, VeriPark’s selection for the Financial Services Partner Advisory Council highlights its role in shaping Microsoft’s financial services strategies and product roadmaps. As a PAC member, VeriPark will provide feedback on Microsoft’s financial services solutions and gain early insights into future roadmaps.

About VeriPark 

VeriPark is a global solutions provider enabling financial institutions to become digital leaders by placing Customer Experience at the core of digital transformation. VeriPark’s Intelligent Customer Experience suite delivers world class customer journeys on digital and assisted channels.

With its main offices located in the United Kingdom, Europe, North America, Asia, Africa and the Middle East, VeriPark helps financial institutions to enhance customer acquisition, retention and cross-sell capabilities. Their proven, secure, and scalable solutions cover Customer Engagement, Omni-Channel Delivery, Branch Automation, and Loan Origination. VeriPark collaborates with clients, crafting innovative technology strategies and solutions, that impact millions of people daily, bringing the promise of digital transformation to life.

Logo – https://mma.prnewswire.com/media/2447880/VeriPark_Logo.jpg

Advertisement

View original content:https://www.prnewswire.co.uk/news-releases/veripark-receives-microsoft-business-applications-20242025-inner-circle-award-and-joins-partner-advisory-council-302253197.html

• Acquisition of Massachusetts-based PFT software partner to strengthen Vitalograph’s US commercial footprint and ability to meet growing global demand for advanced PFT solutions.

BOSTON and ENNIS, Ireland, Sept. 23, 2024 /PRNewswire/ — Vitalograph has today announced the acquisition of Massachusetts-based Morgan Scientific, a long-term partner of the respiratory diagnostics leader, strengthening its U.S. commercial footprint and enabling it to meet the growing global demand for its innovative solutions, particularly in advanced pulmonary function testing solutions.

Speaking of the acquisition, Frank Keane, CEO of Vitalograph said: “We have a long and successful relationship with Morgan Scientific. This agreement is the natural progression for both companies as our combined expertise allows us to focus on delivering the best possible diagnostic solutions that can enable a better understanding of lung health.”

Morgan Scientific is an expert in customer-facing software for advanced PFT systems. ComPAS2, the company’s flagship software powers Vitalograph’s innovative range of advanced PFT solutions, the VitaloPFT Series. Morgan Scientific is also a key distributor for Vitalograph’s pulmonary function testing solutions in the US.

Speaking of their collaboration to date, Mr Keane said: “The recent creation of the VitaloPFT Series has given us valuable experience in working as a team and built mutual respect for our individual expertise. Morgan Scientific is a natural complement to the Vitalograph brand, and this development brings incredible value to our customers all over the world. This acquisition paves the way for us to develop our comprehensive PFT range further.”

He continued: “Vitalograph is a family-owned company and recognises the pioneering drive of the Morgan family to create a business founded on people, integrity, quality, and innovation. These values are at the heart of Vitalograph and are instilled in every part of our business today.”

Gareth Morgan, son of the founder of Morgan Scientific said: “There is no other company in the world that we trust to uphold our legacy of innovation and to continue to put the needs of customers at the forefront of every decision. Joining a globally present and renowned brand such as Vitalograph will enable us to concentrate our efforts on building the business through what we know best – excellence in innovation and customer service.”

The acquisition of Morgan Scientific is a key milestone in Vitalograph’s plan to develop its respiratory diagnostics business globally, furthering its goal of providing comprehensive testing solutions that enable the best possible respiratory healthcare. The company is in the middle of an ambitious growth strategy and is on track to treble its respiratory diagnostics business in the four years leading to 2026.

The acquisition coincides with Vitalograph’s 50^th anniversary of operating and growing in Ennis, Ireland.

About Vitalograph – https://vitalograph.com/ie/

Advertisement

Founded in Buckingham in 1963, and with an R&D, engineering, and manufacturing facility in Ennis in County Clare for 50 years, Vitalograph is a leading global provider of respiratory diagnostic solutions and clinical drug trial services. Through the delivery of respiratory diagnostic solutions that are accurate and reliable, healthcare professionals are empowered to give the best possible care to their patients, wherever it is needed. Based in Haverhill, Massachusetts, Morgan Scientific, Inc. is a wholly owned subsidiary of Vitalograph.

For media information:

Edwina Gore, Gore Communications
+353 87 6295323

Laura Colleran, Vitalograph
+ 353 (0)89 4727860
[email protected] 

Photo: https://mma.prnewswire.com/media/2510842/Vitalograph.jpg
Photo: https://mma.prnewswire.com/media/2510843/Vitalograph_1.jpg

View original content:https://www.prnewswire.co.uk/news-releases/vitalograph-acquires-morgan-scientific-to-meet-growing-global-demand-for-respiratory-diagnostic-solutions-302254091.html

OXFORD, England, Sept. 23, 2024 /PRNewswire/ — FluoRok, an Oxford-based start-up, has raised £7.7m to scale-up, manufacture and commercialise novel fluorochemical reagents and battery electrolyte salts. The oversubscribed round was led by BGF alongside Green Generation Fund and included battery specialist Volta Energy Technologies, current investors (Oxford Science Enterprises and University of Oxford), Excellis Holding and angels.

Founded in 2022, FluoRok is a University of Oxford spin-out that has developed an innovative patented method to access fluorochemicals, chemicals containing the element fluorine and key to global energy transition, healthcare and food supply.

With a growing market valued at $24bn, fluorochemical manufacturing relies on a centuries-old, carbon-intensive process centred around hydrogen fluoride (HF), a highly-toxic, hazardous and difficult-to-handle chemical. FluoRok has developed a safe and sustainable approach completely bypassing HF and providing environmentally friendly access to fluorochemicals while reducing process costs. FluoRok’s groundbreaking innovation has gained substantial traction, attracting numerous potential customers across core markets of Li-ion battery electrolyte salts and agrochemicals.

The funding will support team growth and expanded production facilities for the initial supply of fluorinating reagents and lithium hexafluorophosphate (LiPF₆), a key component of lithium-ion batteries.

Dr Gabriele Pupo, CEO and founder of FluoRok, said: “We are delighted to welcome BGF, Green Generation Fund and Volta Energy Technologies to our investor base. Their experience of building breakthrough businesses in battery and sustainable technologies is invaluable. With an outstanding investor syndicate, we continue our mission to make fluorochemicals production safer, cheaper, and more sustainable. This investment is critical in scaling and commercialising our proprietary technology with partners across the global fluorochemical supply chain, and in accelerating technology that will provide a reliable and localised supply of a key component of Li-ion batteries.”

Dennis Atkinson, investor at BGF, said: “FluoRok’s approach transforms the safety and sustainability of fluorochemical production while reducing costs. Particularly encouraging is significant early demand from customers worldwide and we look forward to supporting FluoRok’s journey to disrupt the global market and reach commercial scale.”

Manon Littek, founding partner at Green Generation Fund, said: “FluoRok’s revolutionary process offers a breakthrough for the fluorination industry, enabling access to compounds fundamental to energy transition, global food supply, and health. As we continue our mission toward a resilient and sustainable future, GGF is thrilled to partner with a future global leader in fluorination and supply chain independence.”

Dr Jeff Chamberlain, CEO and Founder of Volta Energy Technologies said: “Volta is enthused and eager to support FluoRok as it commercialises and scales its unique fluorinating agents. The use of FluoRok’s reagents in the battery industry promises to enable production of fluorinated electrolyte salts, like LiPF₆, without the use of toxic and corrosive hydrofluoric acid. This will reduce barrier-to-entry to the electrolyte industry in Europe and North America. Beyond the battery industry, numerous applications for FluoRok reagents provide potential to have an impact in many global markets.”

Notes:
www.fluorok.com www.bgf.co.uk  www.greengenerationfund.com
www.volta.vc

Enquiries [email protected]

Advertisement

Photo: https://mma.prnewswire.com/media/2507383/FluoRok_Limited_Team.jpg
Logo:  https://mma.prnewswire.com/media/2507382/FluoRok_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/fluorok-raises-7-7m-9-8m-to-transform-the-safety-and-sustainability-of-fluorochemical-production-302252991.html